WHO 2022 & ICC 2022 Hematolymphoid Diagnostic Criteria — 210 WHO + 181 ICC Entities
Users
6
−1 in 30 days
Rating
0.0 / 5
unchanged in 30 days
Ratings
0
0 in 30 days
Store rank
#233K
#195K among extensions
Version
11.0.0
updated 2 Apr 2026
Users
monthly, 6 months
Latest, 15 Oct 2026:6 usersMove the mouse over the chart for any month
Ratings count
monthly, 6 months
Latest, 15 Oct 2026:0 ratingsMove the mouse over the chart for any month
The Chrome Web Store rounds user counts down to the leading digit, so the user line moves in steps. The ratings count is exact and is the better signal of real adoption.
About Classification of Hematolymphoid Tumors
Classification of Hematolymphoid Tumors is a reference tool for
pathologists, hematopathologists, and clinicians. It displays
WHO 2022 and ICC 2022 diagnostic criteria for all major
hematolymphoid neoplasms directly in the Chrome side panel,
keeping criteria accessible without leaving your active tab.
WHAT IT INCLUDES:
- 210 WHO 2022 entities — organized across Myeloid, B-cell,
T/NK-cell, Histiocytic, and Stromal categories
- 181 ICC 2022 entities — with full parallel coverage
- 3-level hierarchy: Classification → Subcategory → Entity
- Diagnostic criteria, immunophenotype, cytogenetics, and
morphologic features for each entity
- Built-in search across all entities
- Entities with interactive diagnostic calculators marked with
a green indicator
FEATURES:
- Side panel integration — stays open alongside any webpage
- Light/dark mode (universal across WHO and ICC)
- Font size adjustment (small / medium / large)
- Fully offline — no internet connection required
- No sign-in, no data collection, no tracking
- Built-in feedback form for reporting errors or suggestions
Designed for daily clinical and academic use in hematopathology.
Based on: Alaggio et al. Leukemia 2022 (WHO 5th ed.) and
Arber et al. Blood 2022 (ICC 2022).